senktide has been researched along with phentolamine in 3 studies
| Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (phentolamine) | Trials (phentolamine) | Recent Studies (post-2010) (phentolamine) |
|---|---|---|---|---|---|
| 292 | 1 | 50 | 9,141 | 270 | 265 |
| Protein | Taxonomy | senktide (IC50) | phentolamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.396 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.006 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.018 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.11 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0173 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.359 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.396 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0011 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0108 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.807 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.5495 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chorev, M; Devor, M; Gilon, C; Papir-Kricheli, D; Selinger, Z | 1 |
| Bealer, SL; Flynn, FW | 1 |
| Bornstein, JC; Johnson, PJ | 1 |
3 other study(ies) available for senktide and phentolamine
| Article | Year |
|---|---|
Neurochemical mediators of the behavioural effects of receptor-selective substance P agonists administered intrathecally in the rat.
Topics: Animals; Injections, Spinal; Male; Methysergide; Morphine; Muscles; Naloxone; Pain; Peptide Fragments; Phentolamine; Phenylephrine; Posture; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord; Stereotyped Behavior; Substance P | 1990 |
Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine.
Topics: Adrenergic alpha-Antagonists; Animals; Cerebral Ventricles; Female; Injections, Intraventricular; Microdialysis; Norepinephrine; Oxytocin; Peptide Fragments; Phentolamine; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Substance P | 2003 |
Neurokinin-1 and -3 receptor blockade inhibits slow excitatory synaptic transmission in myenteric neurons and reveals slow inhibitory input.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Excitatory Postsynaptic Potentials; Female; Guinea Pigs; Male; Myenteric Plexus; Neural Inhibition; Neurokinin-1 Receptor Antagonists; Neurons; Peptide Fragments; Phentolamine; Piperazines; Piperidines; Quinuclidines; Reaction Time; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Substance P; Synaptic Transmission | 2004 |